ReviewFrontiers in nutrition2026
Nutritional intervention targeting muscle-brain axis in dementia continuum: from mechanisms to practice.
Review in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rapid aging of global population has led to an attention increasingly focusing on age-related changes in muscle and cognitive functions, specifically the interplay between sarcopenia, frailty and cognitive impairment as the interconnected geriatric syndromes with major health consequences. Despite being the central pathophysiological substrate across these geriatric syndromes, skeletal muscle loss is still insufficiently prioritized as a treatment objective. Incorporating the "malnutrition-sarcopenia-frailty" triad into dementia care is essential for continuity of management, as muscle preservation is fundamental to sustaining cognitive function within an active aging paradigm. This perspective reframes longevity by shifting emphasis from anticipating frailty to living with strength, valuing added years through resilience rather than decline. This narrative review, prepared by experts in neurology and geriatrics, explores the muscle-brain crosstalk and highlights skeletal muscle loss as a modifiable target for nutritional intervention in cognitive impairment and dementia. In conclusion, given the bidirectional links between malnutrition, sarcopenia, frailty, and cognitive decline through shared aging mechanisms, a high protein oral nutritional supplement [enriched with beta-hydroxy-beta-methylbutyrate (HMB)] and vitamin D emerges as a practical, compliant strategy to support muscle health and potentially contribute to preservation of cognitive health in older adults with or at risk of dementia, although direct evidence for cognitive benefit remains limited.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.